Oliver Lagore Vanvalin Investment Group’s Acadia Healthcare ACHC Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9	Closed	-$608	–	687
2024 Q2	$608	Sell	9 -185	-95%	-$12.9K	﹤0.01%	660
2024 Q1	$15.4K	Buy	194 +22	+13%	+$1.8K	﹤0.01%	369
2023 Q4	$13.4K	Buy	172 +77	+81%	+$5.7K	0.01%	370
2023 Q3	$6.68K	Sell	95 -25	-21%	-$1.87K	﹤0.01%	502
2023 Q2	$9.56K	Buy	120 +9	+8%	+$650	﹤0.01%	468
2023 Q1	$8.02K	Sell	111 -73	-40%	-$5.69K	﹤0.01%	415
2022 Q4	$15.1K	Buy	184 +43	+30%	+$3.54K	0.01%	310
2022 Q3	$11K	Buy	141 +89	+171%	+$7.11K	0.01%	321
2022 Q2	$4K	Buy	+52	New	+$3.63K	﹤0.01%	430

Other funds holding ACHC

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's ACHC Position: Q3 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Acadia Healthcare (ACHC) in Q3 2024, closing a stake of 9 shares — an estimated $608 sold.

Oliver Lagore Vanvalin Investment Group first reported a position in ACHC in Q2 2022 and held it in 9 quarters. The position peaked at $15.4K in Q1 2024. 311 funds tracked by Wall St. Rank hold ACHC as of Q3 2024.

Oliver Lagore Vanvalin Investment Group reported no remaining Acadia Healthcare position as of Q3 2024 after selling out during the quarter.
Oliver Lagore Vanvalin Investment Group sold 9 Acadia Healthcare shares in Q3 2024, an estimated $608.
Oliver Lagore Vanvalin Investment Group first reported a position in Acadia Healthcare in Q2 2022 and held it in 9 quarters.
Oliver Lagore Vanvalin Investment Group's Acadia Healthcare position peaked at $15.4K in Q1 2024.
311 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2024, filed 4 Nov 2024.